Responding to a question from CNN’s Don Lemon at a CNN town hall in Cincinnati, Ohio, Biden said it could happen “maybe early in the school year,” but he stressed that it didn’t “interfere. Not in science.
“The expectation – they don’t promise me a specific date – but my expectation in speaking to the group of scientists that we have assembled… is that at some point, maybe at the start of the school year, at the end of the school year. August, early September, October, they’ll get final approval saying the (US Food and Drug Administration) said, “No, that’s it. It’s good. “
But while Biden predicts it could happen in the coming months, Dr Anthony Fauci on Tuesday proposed a longer deadline, saying it is “very likely” that data on Covid-19 vaccines in children under 12-year-olds may be available by the start of winter.
“Most likely when you do the age de-escalation study – so we went from 12 to nine, nine to six, six to two, then six months to two years – probably in late fall, at early in the winter, we’ll ‘I’ll have enough data,’ Fauci, director of the National Institute of Allergy and Infectious Diseases, said during a Senate hearing.
Emphasizing that he does not “tell any scientist what to do,” Biden also said the United States Centers for Disease Control and Prevention will likely issue guidelines saying that “everyone under the age of 12 should probably wear a mask at school ”.
Currently, none of the three Covid-19 vaccines used in the United States are available for children under the age of 12. With many schools across the United States now within weeks of reopening for the fall semester, Pfizer, Moderna, and Johnson & Johnson are still conducting clinical trials to assess the safety and effectiveness of vaccines in children under 12 years old.
Data for children ages 5 to 11 could arrive sometime in September, and depending on the results, the company told CNN it could ask the FDA to clear emergency use of the vaccine in the same month. .
Data for 2 to 5 year olds could arrive soon after. For younger children, Pfizer said it could potentially obtain data in October or November and, shortly thereafter, ask the FDA to clear emergency use.
CNN’s Betsy Klein and John Bonifield contributed to this report.